IN

Item 9 Labs CorpOOTC INLB Stock Report

Last reporting period 30 Jun, 2023

Updated 18 Dec, 2024

Last price

Market cap $B

0

Micro

Exchange

OOTC - OTC

INLB Stock Analysis

IN

Uncovered

Item 9 Labs Corp is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-35/100

Low score

Market cap $B

0

Dividend yield

Shares outstanding

147.22 B

Item 9 Labs Corp. is a holding company engaged in investing in cannabis and cannabis-related businesses. The Company produces cannabis and cannabis-derived products and technologies through its Item 9 Labs brand. It offers approximately 75 active cannabis strains and more than 150 differentiated cannabis vaporizer (vape) products, as well as premium concentrates and Orion vape technologies. The Company's Item 9 Labs brand specializes in select products and user experience across several cannabis categories. The Company operates through two segments: Cultivation and Franchising. It sells medical and adult-use cannabis dispensary franchises under its retail brand Unity Rd. Its product lines include Item 9 Labs Flower, Item 9 Labs Concentrates and Orion 710. It offers a variety of strains, such as Candyland, Tres Leches and Jack-Here. Its Item 9 Labs Concentrates include shatter, crumble, badder, THCA, live resin terpene sauce and a spectrum distillate cartridges.

View Section: Eyestock Rating